Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells

Journal of Cellular Physiology

Volumn 226, Issue 9, 2011, Pages 2338-2349

  Li, Chia Yang ^a   Chao, Louis Kuoping ^b   Wang, Shu Chi ^a   Chang, Hon Zu ^a   Tsai, Min Lung ^c   Fang, Shih Hua ^c   Liao, Pei Chun ^d   Ho, Chen Lung ^e,f   Chen, Shui Tein ^g,h   Cheng, Wei Chung ^a   Chiang, Chi Shiun ^a   Kuo, Yueh Hsiung ^b   Hua, Kuo Feng ^b,d   Hsu, Ian C ^a,d  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY OF SPORT   (Taiwan)

^d NATIONAL ILAN UNIVERSITY   (Taiwan)

^e TAIWAN FORESTRY RESEARCH INSTITUTE   (Taiwan)

^f NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HONOKIOL; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; DENDRITIC CELL; ENZYME REPRESSION; INFLAMMATION; MONOCYTE DERIVED DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

BIPHENYL COMPOUNDS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; ENZYME ACTIVATION; HUMANS; INFLAMMATION; LIGNANS; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PHENOTYPE; TH1 CELLS; TH2 CELLS;

MAGNOLIA OFFICINALIS;

EID: 79958701829     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22576     Document Type: Article

References (72)

1. Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383: 787-793.
2. Afzali B, Lombardi G, Lechler RI, Lord GM. 2007. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148: 32-46.
3. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB. 2006. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 4: 621-633.
4. Aiba S, Manome H, Nakagawa S, Mollah ZU, Mizuashi M, Ohtani T, Yoshino Y, Tagami H. 2003. p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2, 4-dinitrochlorobenzene. J Invest Dermatol 120: 390-399.
5. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
6. Ammon C, Meyer SP, Schwarzfischer L, Krause SW, Andreesen R, Kreutz M. 2000. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100: 364-369.
7. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. 2001. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166: 3837-3845.
8. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL. 2003. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278: 35501-35507.
9. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
10. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
11. Battle TE, Arbiser J, Frank DA. 2005. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106: 690-697.
12. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
13. Burgdorf S, Lukacs-Kornek V, Kurts C. 2006. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol 176: 6770-6776.
14. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. 1997a. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787.
15. Cella M, Sallusto F, Lanzavecchia A. 1997b. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10-16.
16. Chambers CA, Allison JP. 1999. Costimulatory regulation of T cell function. Curr Opin Cell Biol 11: 203-210.
17. Chiang J, Shen YC, Wang YH, Hou YC, Chen CC, Liao JF, Yu MC, Juan CW, Liou KT. 2009. Honokiol protects rats against eccentric exercise-induced skeletal muscle damage by inhibiting NF-kappaB induced oxidative stress and inflammation. Eur J Pharmacol 610: 119-127.
18. Coutant KD, de Fraissinette AB, Cordier A, Ulrich P. 1999. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol Sci 52: 189-198.
19. Dabbagh K, Dahl ME, Stepick-Biek P, Lewis DB. 2002. Toll-like receptor 4 is required for optimal development of Th2 immune responses: Role of dendritic cells. J Immunol 168: 4524-4530.
20. de Jong EC, Vieira PL, Kalinski P, Kapsenberg ML. 1999. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 66: 201-204.
21. Dikalov S, Losik T, Arbiser JL. 2008. Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol 76: 589-596.
22. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
23. Duperrier K, Eljaafari A, Dezutter-Dambuyant C, Bardin C, Jacquet C, Yoneda K, Schmitt D, Gebuhrer L, Rigal D. 2000. Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. J Immunol Methods 238: 119-131.
24. Fenton MJ, Golenbock DT. 1998. LPS-binding proteins and receptors. J Leukoc Biol 64: 25-32.
25. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH. 1998. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu Rev Immunol 16: 495-521.
26. Georgakopoulos T, Moss ST, Kanagasundaram V. 2008. Integrin CD11c contributes to monocyte adhesion with CD11b in a differential manner and requires Src family kinase activity. Mol Immunol 45: 3671-3681.
27. Gong C, Shi S, Wang X, Wang Y, Fu S, Dong P, Chen L, Zhao X, Wei Y, Qian Z. 2009. Novel composite drug delivery system for honokiol delivery: Self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel. J Phys Chem B 113: 10183-10188.
28. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667.
29. Huang ZY, Barreda DR, Worth RG, Indik ZK, Kim MK, Chien P, Schreiber AD. 2006. Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. J Leukoc Biol 80: 1553-1562.
30. Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM, Richardson P, Podar K, Le Gouill S, Chauhan D, Tamura K, Arbiser J, Anderson KC. 2005. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 106: 1794-1800.
31. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663.
32. Kelleher M, Beverley PC. 2001. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential. J Immunol 167: 6247-6255.
33. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
34. Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T, Yoshida M. 2010. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. J Pharmacol Exp Ther 332: 541-548.
35. Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, Schuler G, Steinkasserer A. 2001. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 194: 1813-1821.
36. Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park E, Kim J, Park S, Park D. 2005. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med 71: 338-343.
37. Lee JS, Kim SG, Kim HK, Lee TH, Jeong YI, Lee CM, Yoon MS, Na YJ, Suh DS, Park NC, Choi IH, Kim GY, Choi YH, Chung HY, Park YM. 2007. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells. J Cell Physiol 210: 385-397.
38. Li Q, Verma IM. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
39. Li CY, Chiang CS, Tsai ML, Hseu RS, Shu WY, Chuang CY, Sun YC, Chang YS, Lin JG, Chen CS, Huang CL, Hsu IC. 2009. Two-sided effect of Cordyceps sinensis on dendritic cells in different physiological stages. J Leukoc Biol 85: 987-995.
40. Lin YL, Liang YC, Lee SS, Chiang BL. 2005. Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol 78: 533-543.
41. Liou KT, Lin SM, Huang SS, Chih CL, Tsai SK. 2003a. Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats. Planta Med 69: 130-134.
42. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK. 2003b. The anti-inflammatory effect of honokiol on neutrophils: Mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475: 19-27.
43. Liu Y, Chen L, He X, Fan L, Yang G, Chen X, Lin X, Du L, Li Z, Ye H, Mao Y, Zhao X, Wei Y. 2008. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma. Int J Gynecol Cancer 18: 652-659.
44. Lo YC, Teng CM, Chen CF, Chen CC, Hong CY. 1994. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol 47: 549-553.
45. Martich GD, Boujoukos AJ, Suffredini AF. 1993. Response of man to endotoxin. Immunobiology 187: 403-416.
46. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145.
47. Munroe ME, Arbiser JL, Bishop GA. 2007. Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179: 753-763.
48. Munroe ME, Businga TR, Kline JN, Bishop GA. 2010. Anti-inflammatory effects of the neurotransmitter agonist honokiol in a mouse model of allergic asthma. J Immunol 185: 5586-5597.
49. Nakagawa S, Ohtani T, Mizuashi M, Mollah ZU, Ito Y, Tagami H, Aiba S. 2004. p38 Mitogen-Activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells. J Invest Dermatol 123: 361-370.
50. Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, Kim J, Park D. 2004. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol 496: 189-195.
51. Quah BJ, O'Neill HC. 2005. Maturation of function in dendritic cells for tolerance and immunity. J Cell Mol Med 9: 643-654.
52. Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N. 1997. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 90: 3640-3646.
53. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188: 2175-2180.
54. Rieser C, Papesh C, Herold M, Bock G, Ramoner R, Klocker H, Bartsch G, Thurnher M. 1998. Differential deactivation of human dendritic cells by endotoxin desensitization: Role of tumor necrosis factor-alpha and prostaglandin E2. Blood 91: 3112-3117.
55. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 181: 2237-2247.
56. Robinson MJ, Cobb MH. 1997. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186.
57. Sadhu C, Ting HJ, Lipsky B, Hensley K, Garcia-Martinez LF, Simon SI, Staunton DE. 2007. CD11c/CD18: Novel ligands and a role in delayed- type hypersensitivity. J Leukoc Biol 81: 1395-1403.
58. Saito S. 2010. Th17 cells and regulatory T cells: New light on pathophysiology of preeclampsia. Immunol Cell Biol 88: 615-617.
59. Scott MJ, Billiar TR. 2008. Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J Biol Chem 283: 29433-29446.
60. Seder RA, Paul WE. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12: 635-673.
61. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY, Liu SH. 2008. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic Biol Med 44: 2043-2050.
62. Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW. 2007. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109: 1279-1289.
63. Squires RF, Ai J, Witt MR, Kahnberg P, Saederup E, Sterner O, Nielsen M. 1999. Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites. Neurochem Res 24: 1593-1602.
64. Thurner B, Roder C, Dieckmann D, Heuer M, Kruse M, Glaser A, Keikavoussi P, Kampgen E, Bender A, Schuler G. 1999. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 223: 1-15.
65. Tse AK, Wan CK, Shen XL, Yang M, Fong WF. 2005. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 70: 1443-1457.
66. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. J Immunol 158: 2919-2925.
67. Watanabe K, Watanabe H, Goto Y, Yamaguchi M, Yamamoto N, Hagino K. 1983. Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: Central depressant effects. Planta Med 49: 103-108.
68. Wen J, Fu AF, Chen LJ, Xie XJ, Yang GL, Chen XC, Wang YS, Li J, Chen P, Tang MH, Shao XM, Lu Y, Zhao X, Wei YQ. 2009. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model. Int J Cancer 124: 2709-2718.
69. Yang SE, Hsieh MT, Tsai TH, Hsu SL. 2002. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 63: 1641-1651.
70. Yang M, Ma C, Sun J, Shao Q, Gao W, Zhang Y, Li Z, Xie Q, Dong Z, Qu X. 2008. Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells. Int Immunopharmacol 8: 1754-1760.
71. Yu Q, Kovacs C, Yue FY, Ostrowski MA. 2004. The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses. J Immunol 172: 6047-6056.
72. Yuan Z, Liu H, Yan F, Wang Y, Gou L, Nie C, Ding Z, Lai S, Zhao Y, Zhao X, Li J, Deng H, Mao Y, Chen L, Wei Y. 2009. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene. Cancer Sci 100: 1757-1766.